An Integrated R&D Center with an Innovative Chinese scientists who have returned from Novartis Institutes for Discovery Platform abroad and graduates from top-tier universi- BioMedical Research As part of the Novartis global drug discovery ties, medical centers, and research institutes network, Novartis Institutes for BioMedical in China. To attract, recruit, and continu- No. 2 BoYun Road Research (NIBR) Shanghai is dedicated to ously develop the best talent, NIBR Shanghai Pudong discovering new therapies that address unmet offers diversified opportunities for profes- Shanghai 201203 medical need in China and Asia. Current sional growth, and fosters a culture that values China research is focused on Asian cancers (such diversity, innovation and collaboration, and as gastric and liver cancer) and liver diseases supports team effectiveness and scientific http://www.nibr.com (such as HBV and hepatic fibrosis). outcomes. The site is home to an epigenetics discovery platform for identifying new classes of targets A Long-term Commitment in China in cancer, while investigating simultaneously Novartis is investing more than $1 billion to the role of epigenetics and identification of develop the new R&D Center located in the potential therapeutic targets in other diseases, midst of the cluster of academic, biotech, such as neurological and psychiatric diseases, and pharmaceutical research institutions in immunomodulatory and pro/anti-inflamma- Shanghai’s Zhangjiang Hi-Tech Park. Once tory pathways, and viral infection or latency, completed, Shanghai will be one of Novartis’ as well as tissue regeneration. top three research centers, along with those in The Center also has programs in biomarker Basel, Switzerland, and Cambridge, MA, USA, development, drug metabolism, and preclini- and the largest in China. cal safety to support Novartis’ local and global A New State-of-the-Art Drug Discovery Campus R&D projects. The Center is designed to support drug discov- Industry and Academic Collaborations ery. The internal spaces will be modular, suited NIBR Shanghai has strong ties with local to the ever-changing needs of science and to academic institutes and biotech companies. the ever-shifting elements of daily life of the Cancer, epigenetics, stem cell study, Next scientists, including lab work, team work, and Generation Sequencing (NGS), bioinformatics, individual contemplation. and synthetic chemistry are some of the areas With a number of internationally well-known NIBR Shanghai is researching with academic architects joining forces on the project, the collaborators and more than 40 local biotech campus will help transform the surrounding and contract research organizations. urban environment as well, highlighting the flow of exterior vistas, and providing secluded Talent Development courtyards reminiscent of tea houses. With approximately 300 associates and grow- The first phase of the project is scheduled for ing, our research teams are staffed by many completion in mid-2015.